Proposed Data Collection Submitted for Public Comment and Recommendations, 52974-52975 [2022-18583]
Download as PDF
<![CDATA[
52974
Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices52957
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)).
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than September 29, 2022.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Bancorp of New Glarus, Inc., New
Glarus, Wisconsin; to acquire First
National Bank at Darlington, Darlington,
Wisconsin.
Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2022–18679 Filed 8–29–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–22–22IJ; Docket No. CDC–2022–
0104]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Evaluation of Safe Spaces in CDCdirectly funded Community-based
Organizations (CBOs). This project is
designed to collect data from persons
attending safe spaces, CBO staff
perceptions of safe spaces, and
descriptions of those spaces selected
from 10 CBOs funded through
Comprehensive High-Impact HIV
Prevention Programs for young men of
Color who have sex with men and
young transgender persons of Color.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:34 Aug 29, 2022
Jkt 256001
CDC must receive written
comments on or before October 31,
2022.
DATES:
You may submit comments,
identified by Docket No. CDC–2022–
0104 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7570; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
ADDRESSES:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of Safe Spaces in CDCdirectly funded Community-based
Organizations (CBOs)—New—National
Centers for HIV, Viral Hepatitis, STD,
and TB Prevention (NCHHSTP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The CDC-funded HIV prevention
program for young men of Color who
have sex with men (YMSM) and young
transgender persons (YTG) of Color
employs an innovative strategy to
address the social determinants of
health (e.g., housing, employment) that
contribute to health inequities and
impact HIV outcomes: safe spaces. Safe
spaces are culturally, linguistically, and
age-appropriate physical spaces for
engaging people who are at increased
risk for HIV and providing HIV
prevention and care activities. Under
this program, funded community-based
organizations (CBOs) must address at
least two social determinants of health
within their safe spaces. CBOs will
employ a community-driven approach
and work with people who are at
increased risk for HIV to select social
determinants of health with the most
potential to reduce barriers to accessing
HIV prevention and care services and
promote health equity.
The purpose of this data collection is
to assess the implementation of safe
spaces, participant perceptions about
the role of space spaces in addressing
social determinants of health and
promoting HIV prevention and care, and
the association between safe space
implementation and HIV process and
outcome indicators. The primary
objectives of this data collection are to
obtain data to: (a) describe the
implementation of safe spaces; (b) to
describe the impact on participants
served; and (c) identify successful
models for safe spaces to inform other
CBOs and CDC.
By describing safe spaces and their
impact on HIV-related outcomes, this
data collection provides an important
data source for evaluating a public
E:\FR\FM\30AUN1.SGM
30AUN1
52975
Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices
health strategy aimed at reducing new
infections, increasing HIV testing, and
prioritizing populations at high risk for
acquiring HIV.
The CDC requests approval for a twoyear information collection. Data are
collected through surveys with
participants of the safe spaces and
phone-based interviews conducted with
safe space staff. Persons attending the
safe spaces are young men who have sex
with men and young transgender
persons of Color over the age of 18. A
brief eligibility screener will be used to
determine eligibility for participation in
the participant survey. No other federal
agency systematically collects this type
of information from persons attending
safe spaces. These data may inform
prevention program development and
monitoring at both the local and
national levels.
CDC estimates that this data
collection will involve, eligibility
screening for 1,250 persons, and a
participant survey for 1,000 eligible
respondents at 10 CBOs, annually. At
each CBO, two staff members will be
interviewed about their perceptions of
safe spaces, totaling 20 staff interviews.
CDC requests OMB approval for an
estimated 369 annual burden hours.
Participation of respondents is
voluntary and there is no cost to the
respondents other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Total
burden
(in hours)
Form name
Persons Screened ............................
Eligible Participants ...........................
Community-based organization staff
Eligibility Screener ............................
Participant survey .............................
Staff interview ...................................
1,250
1,000
20
1
1
1
5/60
15/60
45/60
104
250
15
Total ...........................................
...........................................................
........................
........................
........................
369
Jeffery M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–18583 Filed 8–29–22; 8:45 am]
BILLING CODE 4163–18–P
Vaccine Injury Compensation Program,
5600 Fishers Lane, Room 08N146B,
Rockville, Maryland 20857; (301) 443–
6593, or visit our website at: https://
www.hrsa.gov/vaccinecompensation/
index.html.
The
Program provides a system of no-fault
compensation for certain individuals
who have been injured by specified
childhood vaccines. Subtitle 2 of Title
XXI of the PHS Act, 42 U.S.C. 300aa–
10 et seq., provides that those seeking
compensation are to file a petition with
the United States Court of Federal
Claims and to serve a copy of the
petition to the Secretary of HHS, who is
named as the respondent in each
proceeding. The Secretary has delegated
this responsibility under the Program to
HRSA. The Court is directed by statute
to appoint special masters who take
evidence, conduct hearings as
appropriate, and make initial decisions
as to eligibility for, and amount of,
compensation.
A petition may be filed with respect
to injuries, disabilities, illnesses,
conditions, and deaths resulting from
vaccines described in the Vaccine Injury
Table (the Table) set forth at 42 CFR
100.3. This Table lists for each covered
childhood vaccine the conditions that
may lead to compensation and, for each
condition, the time period for
occurrence of the first symptom or
manifestation of onset or of significant
aggravation after vaccine
administration. Compensation may also
be awarded for conditions not listed in
the Table and for conditions that are
manifested outside the time periods
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Vaccine Injury Compensation
Program; List of Petitions Received
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
HRSA is publishing this
notice of petitions received under the
National Vaccine Injury Compensation
Program (the Program), as required by
the Public Health Service (PHS) Act, as
amended. While the Secretary of HHS is
named as the respondent in all
proceedings brought by the filing of
petitions for compensation under the
Program, the United States Court of
Federal Claims is charged by statute
with responsibility for considering and
acting upon the petitions.
FOR FURTHER INFORMATION CONTACT: For
information about requirements for
filing petitions, and the Program in
general, contact Lisa L. Reyes, Clerk of
Court, United States Court of Federal
Claims, 717 Madison Place NW,
Washington, DC 20005, (202) 357–6400.
For information on HRSA’s role in the
Program, contact the Director, National
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
responses per
respondent
Type of respondents
VerDate Sep<11>2014
17:24 Aug 29, 2022
Jkt 256001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
specified in the Table, but only if the
petitioner shows that the condition was
caused by one of the listed vaccines.
Section 2112(b)(2) of the PHS Act, 42
U.S.C. 300aa–12(b)(2), requires that
‘‘[w]ithin 30 days after the Secretary
receives service of any petition filed
under section 2111 the Secretary shall
publish notice of such petition in the
Federal Register.’’ Set forth below is a
list of petitions received by HRSA on
July 1, 2022, through July 31, 2022. This
list provides the name of petitioner, city
and state of vaccination (if unknown
then city and state of person or attorney
filing claim), and case number. In cases
where the Court has redacted the name
of a petitioner and/or the case number,
the list reflects such redaction. Section
2112(b)(2) also provides that the special
master ‘‘shall afford all interested
persons an opportunity to submit
relevant, written information’’ relating
to the following:
1. The existence of evidence ‘‘that
there is not a preponderance of the
evidence that the illness, disability,
injury, condition, or death described in
the petition is due to factors unrelated
to the administration of the vaccine
described in the petition,’’ and
2. Any allegation in a petition that the
petitioner either:
a. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition not set forth in the
Vaccine Injury Table but which was
caused by’’ one of the vaccines referred
to in the Table, or
b. ‘‘[S]ustained, or had significantly
aggravated, any illness, disability,
injury, or condition set forth in the
Vaccine Injury Table the first symptom
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 87, Number 167 (Tuesday, August 30, 2022)]
[Notices]
[Pages 52974-52975]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18583]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22IJ; Docket No. CDC-2022-0104]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Evaluation of Safe Spaces in CDC-
directly funded Community-based Organizations (CBOs). This project is
designed to collect data from persons attending safe spaces, CBO staff
perceptions of safe spaces, and descriptions of those spaces selected
from 10 CBOs funded through Comprehensive High-Impact HIV Prevention
Programs for young men of Color who have sex with men and young
transgender persons of Color.
DATES: CDC must receive written comments on or before October 31, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0104 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Evaluation of Safe Spaces in CDC-directly funded Community-based
Organizations (CBOs)--New--National Centers for HIV, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The CDC-funded HIV prevention program for young men of Color who
have sex with men (YMSM) and young transgender persons (YTG) of Color
employs an innovative strategy to address the social determinants of
health (e.g., housing, employment) that contribute to health inequities
and impact HIV outcomes: safe spaces. Safe spaces are culturally,
linguistically, and age-appropriate physical spaces for engaging people
who are at increased risk for HIV and providing HIV prevention and care
activities. Under this program, funded community-based organizations
(CBOs) must address at least two social determinants of health within
their safe spaces. CBOs will employ a community-driven approach and
work with people who are at increased risk for HIV to select social
determinants of health with the most potential to reduce barriers to
accessing HIV prevention and care services and promote health equity.
The purpose of this data collection is to assess the implementation
of safe spaces, participant perceptions about the role of space spaces
in addressing social determinants of health and promoting HIV
prevention and care, and the association between safe space
implementation and HIV process and outcome indicators. The primary
objectives of this data collection are to obtain data to: (a) describe
the implementation of safe spaces; (b) to describe the impact on
participants served; and (c) identify successful models for safe spaces
to inform other CBOs and CDC.
By describing safe spaces and their impact on HIV-related outcomes,
this data collection provides an important data source for evaluating a
public
[[Page 52975]]
health strategy aimed at reducing new infections, increasing HIV
testing, and prioritizing populations at high risk for acquiring HIV.
The CDC requests approval for a two-year information collection.
Data are collected through surveys with participants of the safe spaces
and phone-based interviews conducted with safe space staff. Persons
attending the safe spaces are young men who have sex with men and young
transgender persons of Color over the age of 18. A brief eligibility
screener will be used to determine eligibility for participation in the
participant survey. No other federal agency systematically collects
this type of information from persons attending safe spaces. These data
may inform prevention program development and monitoring at both the
local and national levels.
CDC estimates that this data collection will involve, eligibility
screening for 1,250 persons, and a participant survey for 1,000
eligible respondents at 10 CBOs, annually. At each CBO, two staff
members will be interviewed about their perceptions of safe spaces,
totaling 20 staff interviews. CDC requests OMB approval for an
estimated 369 annual burden hours. Participation of respondents is
voluntary and there is no cost to the respondents other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Persons Screened.............. Eligibility 1,250 1 5/60 104
Screener.
Eligible Participants......... Participant 1,000 1 15/60 250
survey.
Community-based organization Staff interview. 20 1 45/60 15
staff.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 369
----------------------------------------------------------------------------------------------------------------
Jeffery M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-18583 Filed 8-29-22; 8:45 am]
BILLING CODE 4163-18-P
